ADICET BIO INC (ACET)
US0070021086 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 159.71M | 257.70M | 277.50M | 84.30M | 10.60M | |||
| Marketable Securities | N/A | N/A | 0.00 | 10.30M | 51.80M | |||
| Receivables | 0.00 | 400.00K | 200.00K | 2.70M | 900.00K | |||
| Other Current Assets | 2.56M | 2.90M | 4.70M | 3.00M | 900.00K | |||
| Total Current Assets | 162.27M | 261.00M | 282.40M | 100.30M | 64.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.20M | 49.00M | 35.00M | 25.90M | 2.10M | |||
| Investments And Advances | N/A | N/A | 0.00 | 0.00 | 10.60M | |||
| Goodwill | 0.00 | 19.50M | 19.50M | 20.10M | 0.00 | |||
| Intangibles | N/A | N/A | 0.00 | 1.20M | 0.00 | |||
| Other Non-Current Assets | 822.00K | 1.20M | 2.00M | 6.40M | 4.70M | |||
| Total Non-Current Assets | 45.02M | 69.70M | 56.50M | 53.50M | 17.40M | |||
| TOTAL ASSETS | 207.29M | 330.70M | 338.90M | 153.80M | 81.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.66M | 15.30M | 8.20M | 6.90M | 2.80M | |||
| Accounts Payable | 2.63M | 4.40M | 3.30M | 1.60M | 1.10M | |||
| Other Current Liabilities | N/A | 0.00 | 4.80M | 14.00M | 11.00M | |||
| Total Current Liabilities | 19.29M | 19.70M | 16.30M | 22.50M | 14.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 100.00K | 0.00 | |||
| Other Non-Current Liabilities | 17.83M | 18.60M | 19.50M | 21.40M | 13.00M | |||
| Total Non-Current Liabilities | 17.83M | 18.70M | 19.50M | 21.50M | 13.00M | |||
| TOTAL LIABILITIES | 37.12M | 38.40M | 35.80M | 44.00M | 27.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -380.77M | -238.10M | -168.30M | -106.30M | -69.60M | |||
| Additional Paid In Capital | 550.94M | 530.40M | 471.40M | 216.10M | 9.30M | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 0.00 | 114.10M | |||
| Other Shareholders' Equity | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 43.27M | 43.00M | 39.70M | 19.70M | 300.00K | |||
| Tangible Book Value per Share | 3.93 | 6.34 | 7.14 | 4.49 | -201.33 | |||
| Total Shareholders' Equity | 170.18M | 292.30M | 303.10M | 109.80M | 53.70M | |||
| TOTAL LIABILITIES AND EQUITY | 207.29M | 330.70M | 338.90M | 153.80M | 81.60M | |||
| Statistics | ||||||||
| Current Ratio | 8.41 | 13.25 | 17.33 | 4.46 | 4.31 | |||
| Return On Assets (ROA) | -68.82% | -21.10% | -18.29% | -23.85% | -101.40% | |||
| Return On Equity (ROE) | -83.83% | -23.88% | -20.46% | -33.41% | -154.08% | |||
All data in USD